Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial.

Vissing NH, Skajaa T, Grosen D, Albertsen BK, Als-Nielsen B, Hasle H, Koch MM, Rasmussen AH, Brok JS, Hjalgrim L, Blanche P, Schmiegelow K, Nygaard U.

Open source

DOI
10.1016/s2352-4642(26)00039-8
Published
2026-04-13
Container
Lancet Child Adolesc Health
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2352-4642-26-00039-8,
  title = {Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial.},
  author = {Vissing NH and  Skajaa T and  Grosen D and  Albertsen BK and  Als-Nielsen B and  Hasle H and  Koch MM and  Rasmussen AH and  Brok JS and  Hjalgrim L and  Blanche P and  Schmiegelow K and  Nygaard U.},
  year = {2026},
  journal = {Lancet Child Adolesc Health},
  doi = {10.1016/s2352-4642(26)00039-8},
  url = {https://doi.org/10.1016/s2352-4642(26)00039-8}
}

RIS

TY  - JOUR
TI  - Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial.
AU  - Vissing NH
AU  -  Skajaa T
AU  -  Grosen D
AU  -  Albertsen BK
AU  -  Als-Nielsen B
AU  -  Hasle H
AU  -  Koch MM
AU  -  Rasmussen AH
AU  -  Brok JS
AU  -  Hjalgrim L
AU  -  Blanche P
AU  -  Schmiegelow K
AU  -  Nygaard U.
PY  - 2026
JO  - Lancet Child Adolesc Health
DO  - 10.1016/s2352-4642(26)00039-8
UR  - https://doi.org/10.1016/s2352-4642(26)00039-8
ER  - 

APA

NH, V., T, S., D, G., BK, A., B, A., H, H., MM, K., AH, R., JS, B., L, H., P, B., K, S., & U., N. (2026). Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial.. Lancet Child Adolesc Health. https://doi.org/10.1016/s2352-4642(26)00039-8

Source records